StockData
Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.81−0.09 (-4.74%)

Close on Nov 18, 2026Market cap $18.06MP/E –Yield –

Atossa Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Atossa Therapeutics's revenue for the twelve months ending Sep 30, 2016 was $1.76K. For fiscal 2015 it was $1.76K, down 95.6% from the year before. The highest annual figure on record is $632.56K in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2015Dec 31, 2015$1.76K-95.6%
FY2014Dec 31, 2014$40.14K-93.7%
FY2013Dec 31, 2013$632.56K+31.3%
FY2012Dec 31, 2012$481.84K+32022.8%
FY2011Dec 31, 2011$1.50K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2016Sep 30, 2016$0–

More Atossa Therapeutics figures

See a number that looks wrong?